driven by the PitchBook Platform
Developer of immuno-sequencing diagnostics. The company offers a technology based on sequencing to provide analysis of the T- and B-cell repertoire in order to support the fights against cancer, auto-immune and other infectious diseases.
You’re viewing a free company profile from the PitchBook Platform. To explore Adaptive Biotechnologies’s full profile, request a free trial.
11 Former Executives
1 Former Board Member
© 2017 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.